Teede, Helena

Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis

Naderpoor, N., Shorakae, S., de Courten, B., Misso, M. L., Moran, L. J., & Teede, H. J. (2015) · Human Reproduction Update

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 334

Association of Antenatal Diet and Physical Activity–Based Interventions With Gestational Weight Gain and Pregnancy Outcomes: A Systematic Review and Meta-analysis

Teede, H. J., Bailey, C., Moran, L. J., Bahri Khomami, M., Enticott, J., Ranasinha, S., Rogozińska, E., Skouteris, H., Boyle, J. A., Thangaratinam, S., et al. (2022) · JAMA Internal Medicine

Gestational Diabetes Research and ManagementMaternal and Neonatal Healthcare

Cited by 329

Metabolic syndrome in polycystic ovary syndrome: a systematic review, meta‐analysis and meta‐regression

Lim, S. S., Kakoly, N. S., Tan, J. W. J., Fitzgerald, G., Bahri Khomami, M., Joham, A. E., Cooray, S. D., Misso, M. L., Norman, R. J., Harrison, C. L., et al. (2019) · Obesity Reviews

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 316

Lifestyle changes in women with polycystic ovary syndrome

Moran, L. J., Hutchison, S. K., Norman, R. J., & Teede, H. J. (2011) · Cochrane Database of Systematic Reviews

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 292

Androgen Excess- Polycystic Ovary Syndrome Society: position statement on depression, anxiety, quality of life, and eating disorders in polycystic ovary syndrome

Dokras, A., Stener-Victorin, E., Yildiz, B. O., Li, R., Ottey, S., Shah, D., Epperson, N., & Teede, H. (2018) · Fertility and Sterility

Ovarian function and disordersEating Disorders and Behaviors

Cited by 285

Overweight Women with Polycystic Ovary Syndrome Have Evidence of Subclinical Cardiovascular Disease

Meyer, C., McGrath, B. P., & Teede, H. J. (2005) · The Journal of Clinical Endocrinology & Metabolism

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 273

Exercise therapy in polycystic ovary syndrome: a systematic review

Harrison, C. L., Lombard, C. B., Moran, L. J., & Teede, H. J. (2011) · Human Reproduction Update

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 267

Dietary Composition in the Treatment of Polycystic Ovary Syndrome: A Systematic Review to Inform Evidence-Based Guidelines

Moran, L. J., Ko, H., Misso, M., Marsh, K., Noakes, M., Talbot, M., Frearson, M., Thondan, M., Stepto, N., & Teede, H. J. (2013) · Journal of the Academy of Nutrition and Dietetics

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 259

Anxiety and depression in polycystic ovary syndrome: a comprehensive investigation

Deeks, A. A., Gibson-Helm, M. E., & Teede, H. J. (2010) · Fertility and Sterility

Ovarian function and disordersReproductive Health and Technologies

Cited by 246

Metabolic risk in PCOS: Phenotype and adiposity impact

Moran, L. J., Norman, R. J., & Teede, H. J. (2015) · Trends in Endocrinology & Metabolism

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 245

Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome

Teede, H. J., Tay, C. T., Laven, J., Dokras, A., Moran, L. J., Piltonen, T. T., Costello, M. F., Boivin, J., Redman, L. M., Boyle, J. A., et al. (2023) · Human Reproduction

Ovarian function and disordersClinical practice guidelines implementation

Cited by 244

Diabetes: A metabolic and reproductive disorder in women

Thong, E. P., Codner, E., Laven, J. S. E., & Teede, H. (2020) · The Lancet Diabetes & Endocrinology

Ovarian function and disordersDiabetes Management and Research

Cited by 242

Depression, anxiety and perceived stress in women with and without PCOS: a community-based study

Damone, A. L., Joham, A. E., Loxton, D., Earnest, A., Teede, H. J., & Moran, L. J. (2019) · Psychological Medicine

Ovarian function and disordersReproductive Health and Technologies

Cited by 230

Gaps in knowledge among physicians regarding diagnostic criteria and management of polycystic ovary syndrome

Dokras, A., Saini, S., Gibson-Helm, M., Schulkin, J., Cooney, L., & Teede, H. (2017) · Fertility and Sterility

Ovarian function and disordersEndometriosis Research and Treatment

Cited by 218

Increased maternal pregnancy complications in polycystic ovary syndrome appear to be independent of obesity—A systematic review, meta‐analysis, and meta‐regression

Bahri Khomami, M., Joham, A. E., Boyle, J. A., Piltonen, T., Silagy, M., Arora, C., Misso, M. L., Teede, H. J., & Moran, L. J. (2019) · Obesity Reviews

Ovarian function and disordersGestational Diabetes Research and Management

Cited by 211

Is having polycystic ovary syndrome a predictor of poor psychological function including anxiety and depression?

Deeks, A. A., Gibson-Helm, M. E., Paul, E., & Teede, H. J. (2011) · Human Reproduction

Ovarian function and disordersReproductive Health and Technologies

Cited by 202

A Summary on Polycystic Ovary Syndrome: Diagnostic Criteria, Prevalence, Clinical Manifestations, and Management According to the Latest International Guidelines

Neven, A., Laven, J., Teede, H., & Boyle, J. (2018) · Seminars in Reproductive Medicine

Ovarian function and disordersEndometriosis Research and Treatment

Cited by 196

Effects of Exercise on Insulin Resistance and Body Composition in Overweight and Obese Women with and without Polycystic Ovary Syndrome

Hutchison, S. K., Stepto, N. K., Harrison, C. L., Moran, L. J., Strauss, B. J., & Teede, H. J. (2011) · The Journal of Clinical Endocrinology & Metabolism

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 192

New Perspectives on the Pathogenesis of PCOS: Neuroendocrine Origins

Walters, K. A., Gilchrist, R. B., Ledger, W. L., Teede, H. J., Handelsman, D. J., & Campbell, R. E. (2018) · Trends in Endocrinology & Metabolism

Ovarian function and disordersHypothalamic control of reproductive hormones

Cited by 186

Inter‐related effects of insulin resistance, hyperandrogenism, sympathetic dysfunction and chronic inflammation in PCOS

Shorakae, S., Ranasinha, S., Abell, S., Lambert, G., Lambert, E., de Courten, B., & Teede, H. (2018) · Clinical Endocrinology

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 176

The Impact of Obesity on the Incidence of Type 2 Diabetes Among Women With Polycystic Ovary Syndrome

Kakoly, N. S., Earnest, A., Teede, H. J., Moran, L. J., & Joham, A. E. (2019) · Diabetes Care

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 174

Comorbidities and complications of polycystic ovary syndrome: An overview of systematic reviews

Gilbert, E. W., Tay, C. T., Hiam, D. S., Teede, H. J., & Moran, L. J. (2018) · Clinical Endocrinology

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 166

Ovarian Function and Obesity—Interrelationship, Impact on Women’s Reproductive Lifespan and Treatment Options

Rachoń, D., & Teede, H. (2010) · Molecular and Cellular Endocrinology

Ovarian function and disordersReproductive Biology and Fertility

Cited by 161

Effects of Medical Therapy on Insulin Resistance and the Cardiovascular System in Polycystic Ovary Syndrome

Meyer, C., McGrath, B. P., & Teede, H. J. (2007) · Diabetes Care

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 148